The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end up with Alzheimer’s disease, and whether it’s the ...

Learn about prostate cancer, its early detection, symptoms, and treatment options. Know the importance of screenings and ...

It is one of the common treatment options for prostate cancer and can be used in various stages of the disease, either alone or in combination with other treatments like surgery or hormone therapy.

Scientists have welcomed a breakthrough in the battle against prostate cancer. Doctors have pinpointed a protein in the ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Prostate removal surgery can lead to multiple side effects. Some, such as incontinence and erectile dysfunction, can be ...

Prostate cancer, which develops in the prostate gland, primarily affects older men, but younger men with a family history are ...

One of the most commonly diagnosed cancers among men, and the second-leading cause of cancer death among men, prostate cancer ...

Prostate cancer treatments often impact sexual wellness, causing erectile dysfunction and decreased libido. Effective ...

Scientists have discovered that a protein linked to prostate cancer is associated with more ... help predict who will become resistant to hormone therapy. A targeted radioactive infusion that ...

When Andy Keen, then 57, found he needed to urinate more frequently he put it down to his age but it was a sign of something ...